Harbor国际股票主动型ETF EPIN 深 沪
已收盘 03-27 16:00:00 美东时间
22.6056
-0.248
-1.09%
华盛通- 最 高22.6056
- 今 开--
- 成交量 0股
- 最 低 22.6056
- 昨 收 22.8539
- 总市值 621.65万
- 52周最高 25.556
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 19.7442
- 委 比 0.00%
- 总股本 27.50万
- 历史最高 25.556
- 量 比 0
- 振 幅 0.00%
- 历史最低 19.7442
- 每 手 1
- 风险率 1.53%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BRIEF-Ars Pharmaceuticals Receives FDA Approval To Remove Age Requirement From Neffy® 1 Mg (Epinephrine Nasal Spray) Label
BRIEF-Ars Pharmaceuticals Receives FDA Approval To Remove Age Requirement From Neffy® 1 Mg (Epinephrine Nasal Spray) Label ARS Pharmaceuticals Inc SPRY.O : ARS PHARMACEUTICALS RECEIVES FDA APPROVAL TO REMOVE AGE REQUIREMENT FROM NEFFY® 1 MG (EPINEPHRINE NASAL SPRAY) LABEL Source text: ID:nGNX7Knd3h
03-27 20:07
BRIEF-Nasus Pharma Announces Positive Top Line Data From Phase 2 Clinical Study Of Ns002 Achieves Significantly Superior And Faster Epinephrine Delivery Compared To Epipen® With Accelerated Speed To Therapeutic Threshold
BRIEF-Nasus Pharma Announces Positive Top Line Data From Phase 2 Clinical Study Of Ns002 Achieves Significantly Superior And Faster Epinephrine Delivery Compared To Epipen® With Accelerated Speed To Therapeutic Threshold March 16 (Reuters) - Nasus Pharma Ltd NSRX.A : NASUS PHARMA ANNOUNCES POSITIVE
03-16 19:38
BRIEF-Fresenius Kabi Oncology Ltd Co And Phlow Corp Announce End-To-End, U.S. Manufacturing Collaboration For Epinephrine Injection
BRIEF-Fresenius Kabi Oncology Ltd Co And Phlow Corp Announce End-To-End, U.S. Manufacturing Collaboration For Epinephrine Injection Feb 9 (Reuters) - Fresenius Kabi Oncology Ltd FRES.M3 : FRESENIUS KABI ONCOLOGY LTD: CO AND PHLOW CORP ANNOUNCE END-TO-END, U.S. MANUFACTURING COLLABORATION FOR EPINEPH
02-09 22:56
BRIEF-Fresenius Says Fresenius Kabi Enters Partnership With U.S. Phlow To Establish Supply Chain For Epinephrine
BRIEF-Fresenius Says Fresenius Kabi Enters Partnership With U.S. Phlow To Establish Supply Chain For Epinephrine Feb 9 (Reuters) - FRESENIUS SE & CO KGAA FREG.DE : FRESENIUS KABI ENTERS PARTNERSHIP WITH U.S. MANUFACTURER PHLOW CORP. TO ESTABLISH A DOMESTIC, END TO END SUPPLY CHAIN FOR EPINEPHRINE IN
02-09 22:30
BRIEF-Modon Holding Forms JV With Related Companies And Panepinto Properties To Deliver Harborside 4
Dec 22 (Reuters) - Modon Holding PSC MODON.AD: MODON HOLDING - FORMS JV WITH RELATED COMPANIES AND PANEPINTO PROPERTIES TO DELIVER HARBORSIDE 4 MODON HOLDING - MODON ACQUIRES A MAJORITY EQUITY STAKE I...
2025-12-22 12:10
BRIEF-Amneal Receives U.S. FDA Approval For Epinephrine Injection
Dec 9 (Reuters) - Amneal Pharmaceuticals Inc AMRX.O: AMNEAL RECEIVES U.S. FDA APPROVAL FOR EPINEPHRINE INJECTION IN SINGLE- AND MULTI-DOSE VIALS FOR U.S. HOSPITALS Source text: ID:nGNXhc7Lv Further co...
2025-12-10 05:04
BRIEF-ARS Pharmaceuticals Receives Favorable Decision From European Patent Office On Patent Related To Neffy® (Epinephrine Nasal Spray)
Oct 8 (Reuters) - ARS Pharmaceuticals Inc SPRY.O: ARS PHARMACEUTICALS RECEIVES FAVORABLE DECISION FROM EUROPEAN PATENT OFFICE ON PATENT RELATED TO NEFFY® (EPINEPHRINE NASAL SPRAY) ARS PHARMACEUTICALS ...
2025-10-08 20:10
BRIEF-Robo.ai Invests In DePIN Project Arkreen, Exploring Web3 Technology And Machine Economy Integration
Sept 18 (Reuters) - Robo.ai Inc AIIO.O: ROBO.AI INVESTS IN DEPIN PROJECT ARKREEN, EXPLORING WEB3 TECHNOLOGY AND MACHINE ECONOMY INTEGRATION Source text: ID:nPn3SwTZ3a Further company coverage: AIIO.O ...
2025-09-18 21:20
BRIEF-Abcourt Announces Increase To Loan Financing With Nebari
Sept 10 (Reuters) - Abcourt Mines Inc ABI.V: ABCOURT ANNOUNCES INCREASE TO LOAN FINANCING WITH NEBARI TO ACCELERATE SLEEPING GIANT MINE DEVELOPMENT ABCOURT MINES INC - SECURES $2 MILLION UPSIZED LOAN ...
2025-09-10 23:23
BRIEF-Aquestive Therapeutics Announces $75M Strategic Funding Agreement with RTW
Aug 14 (Reuters) - Aquestive Therapeutics Inc AQST.O: AQUESTIVE THERAPEUTICS ANNOUNCES $75M STRATEGIC FUNDING AGREEMENT WITH RTW TO SUPPORT THE POTENTIAL LAUNCH OF ANAPHYLM™ (EPINEPHRINE) SUBLINGUAL F...
2025-08-14 18:27
